Moore Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Moore Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200,000	Closed	-$34.6M	–	581
2015 Q1	$34.6M	Buy	+200,000	New	+$29.4M	0.76%	17

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Moore Capital Management's SLXP Position: Q1 2015 in Review

Moore Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 10,000 shares — an estimated $1.47M sold.

Moore Capital Management first reported a position in SLXP in Q4 2014 and held it in 1 quarter. The position peaked at $1.15M in Q4 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Moore Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Moore Capital Management sold 10,000 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $1.47M.
Moore Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 1 quarter.
Moore Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.15M in Q4 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Moore Capital Management's 13F filing for Q1 2015, filed 15 May 2015.